Supha Pharmachem Share Price
0.27+0.01 (+3.85%)
-82.24% past 1 Year
Corporate filings & documents
Announcements
Disclosure under Regulation 30 of SEBI (LODR) 2015
2 months agoDisclosure under Regulation 30 of SEBI (LODR) 2015
2 months agoIntimation for closure of Trading Window
2 months agoIntimation for closure of Trading Window
2 months agoAppointment of Resolution Professional in place of Interim Resolution Professional
4 months agoAppointment of Resolution Professional in place of Interim Resolution Professional
4 months agoDisclosure to take note of decisions taken in 1st COC meeting held on 14.04.2026
5 months agoDisclosure to take note of decisions taken in 1st COC meeting held on 14.04.2026
5 months agoThis disclosure is to place on record List of Creditors as required to be placed under Reg 13(2)(c) of IBBI CIRP Regulations
5 months agoThis disclosure is to place on record List of Creditors as required to be placed under Reg 13(2)(c) of IBBI CIRP Regulations
5 months agoUpdate on CIRP Proceedings Non-Cooperation by Directors (Power suspended) and Postponement of Board Meeting under Regulation 30 of SEBI (LODR) Regulation 2015
5 months agoUpdate on CIRP Proceedings Non-Cooperation by Directors (Power suspended) and Postponement of Board Meeting under Regulation 30 of SEBI (LODR) Regulation 2015
5 months agoClosure of Trading window
5 months agoIntimation of receipt of Order from National Company Law Tribunal (NCLT)
6 months agoSubmission of Form A - PUBLIC ANNOUNCEMENT
6 months agoIntimation for Admission of Co. under CIRP and appointment of IRP
6 months agoIntimation of change in registered office of the company to office no. F81D Express Zone Mall A wing Next to Patel Vanika W.E. Highway Goregaon (East) Mumbai - 400063 w.e.f. 17th March 2026 .
6 months agoIntimation of change in registered office of the company to office no. F81D Express Zone Mall A wing Next to Patel Vanika W.E. Highway Goregaon (East) Mumbai - 400063 w.e.f. 17th March 2026 .
6 months agoSupha Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/03/2026 inter alia to consider and approve To consider Un-Audited Financial Results/Statements (Standalone & Consolidated) of the Company for the Third Quarter and Nine months ended December 31 2025 and update on Trading Window
6 months agoSupha Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/03/2026 inter alia to consider and approve unaudited standalone and consolidated quarterly results 31.12.2025
6 months agoSupha Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/03/2026 inter alia to consider and approve unaudited standalone and consolidated quarterly results 31.12.2025
6 months agoSupha Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/02/2026 inter alia to consider and approve unaudited standalone and consolidated quarterly results 31.12.2025 on 25.02.2026
7 months agoRescheduling on 25/02/2026
7 months agoDemise of CS and Compliance Officer
7 months agoSupha Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve Un-Audited Financial Results/Statements (Standalone & Consolidated) of the Company for the Third Quarter and Nine months ended December 31 2025
7 months agoSubmission of Reg. 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 31.12.2025
8 months agoIntimation of closure of Trading Window
9 months agoCompany is pleased to informed that MCA has approved the change of name vide certificate of incorporation W.E.F. 15/12/2025 from REMEDIUM LIFECARE LTD. TO SUPHA PHARMACHEM LIMITED
9 months agoSubmission of postal ballot results and scrutinizer report
9 months agoSubmission of outcome of postal ballot
9 months agoNewspaper Publication for unaudited financial results 30.09.2025
10 months agoRemedium Lifecare Delivers Strong Q2 Results with Profit Nearly Doubling to Rs.862.34 Lakh
10 months agoFinancial Results for Quarter and Half Year ended September 30 2025
10 months agoBoard Meeting Outcome for The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter and Half year Ended September 30 2025
10 months agoRemedium Lifecare Strengthens Leadership for Next-Phase Growth
10 months agoRemedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve Unaudited Standalone and consolidated results for quarter and half year ended 30.09.2025
10 months agoNewspapers publication for dispatch of postal ballot notice
10 months agoSubmission of postal ballot notice
10 months agoAppointment
10 months agothe Board in ite metting approved 1. Appointed Mr. Rambhajan Vishwakarma . 2. Appointed Mr. Vignesh Laxman Gawde . 3. Approved the Postal Ballot notices 4. The Board has reconstituted its committee(s) on account of change in board members
10 months agoResignation of Mr. Mansoor Abdul Vahab
10 months agoCompliance certificate under Reg. 74(5) of SEBI (DP) 30.09.2025
11 months agoResignation of Mr. Dipesh Vaidya Non- Executive Independent Director
11 months agoe-voting results of AGM and scrutinizer Report of AGM held on 24.09.2025 through VC/OAVM
12 months agoProceedings of 36th AGM held on 24.09.2025 through VC/OAVM
12 months agoIntimation of closure of trading window
12 months agoWe wish to inform you that the Board of Directors of the Company at its meeting held today 22nd September 2025 has inter- alia considered approved and taken on record 1. Change of Name of the Company 2. Increase in Authorised Share Capital and 3. Proposal for Further Capital Raising
12 months agoAnnual reports
Concalls & investor presentations
No presentations found